Additionally, a previous study suggested the presence of the co-expression of ISL1 and KDM6B in NAFLD and that ISL1 could interact with KDM6B (Wang et al. 2016). Here, KDM6B is linked to metabolic dysfunction-associated steatotic liver disease.